Tocilizumab Subcutaneous Injection (RoActemra®)
The supply of Tocilizumab Subcutaneous Injections (RoActemra®) to NHS Scotland which used to treat licensed indications. This medicine is not being procured to treat Covid-19.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£25,050,684
Published
3 Feb 2021
Closes
3 Feb 2021
Procurement details
Source
Find a Tender
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Tocilizumab Subcutaneous Injection (RoActemra®)
£25,050,684
Supply of Tocilizumab Subcutaneous Injections (RoActemra®) to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line.
Delivery: Scotland
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.